These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3334157)

  • 21. [A multicentre study of Shigella spp in Henan province, during 2000-2007].
    Xu LY; Xu BL; Guo WS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):203. PubMed ID: 19565889
    [No Abstract]   [Full Text] [Related]  

  • 22. [The pathogenic properties of streptomycin-dependent mutants of Sh. flexneri and its revertants].
    Mikhaĭlov IF; Sergeev VV; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Nov; 45(11):10-4. PubMed ID: 5735219
    [No Abstract]   [Full Text] [Related]  

  • 23. [Virulence plasmids of Shigella bacteria].
    Romanova IuM
    Mol Gen Mikrobiol Virusol; 1991 Jun; (6):3-9. PubMed ID: 1944325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental regulation of Shigella virulence.
    Maurelli AT; Hromockyj AE; Bernardini ML
    Curr Top Microbiol Immunol; 1992; 180():95-116. PubMed ID: 1324135
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenicity of Shigella in healthy carriers: a study in Vientiane, Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Insisiengmay S; Ichinose Y; Higa N; Song T; Iwanaga M
    Jpn J Infect Dis; 2005 Aug; 58(4):232-4. PubMed ID: 16116257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular biology in the pathogenesis of Shigella sp. and enteroinvasive Escherichia coli].
    Rico-Martínez MG
    Rev Latinoam Microbiol; 1995; 37(4):367-85. PubMed ID: 8900572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On various features of the epidemiology of dysentery in Tashkent. I. On the question of changes in the etiologic structure of dysentery in Tashkent].
    Boĭko VM; Smirnova TT; Nevskiĭ MV; Varsanova EIa
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Apr; 46(4):74-9. PubMed ID: 4239821
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of expression of virulence-associated genes and pathogenesis of pathogenic bacteria .
    Watanabe H
    Nihon Saikingaku Zasshi; 2011 Feb; 66(1):1-5. PubMed ID: 21498961
    [No Abstract]   [Full Text] [Related]  

  • 29. Shigella lipopolysaccharide: structure, genetics, and vaccine development.
    Brahmbhatt HN; Lindberg AA; Timmis KN
    Curr Top Microbiol Immunol; 1992; 180():45-64. PubMed ID: 1380416
    [No Abstract]   [Full Text] [Related]  

  • 30. The Shigella virulence gene regulatory cascade: a paradigm of bacterial gene control mechanisms.
    Dorman CJ; Porter ME
    Mol Microbiol; 1998 Aug; 29(3):677-84. PubMed ID: 9723908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development.
    Sansonetti P; Phalipon A
    Res Immunol; 1996; 147(8-9):595-602. PubMed ID: 9127893
    [No Abstract]   [Full Text] [Related]  

  • 32. The response of man to virulent Shigella flexneri 2a.
    DuPont HL; Hornick RB; Dawkins AT; Snyder MJ; Formal SB
    J Infect Dis; 1969 Mar; 119(3):296-9. PubMed ID: 5780532
    [No Abstract]   [Full Text] [Related]  

  • 33. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.
    Venkatesan M; Fernandez-Prada C; Buysse JM; Formal SB; Hale TL
    Vaccine; 1991 May; 9(5):358-63. PubMed ID: 1872021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
    Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
    Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
    [No Abstract]   [Full Text] [Related]  

  • 35. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
    Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
    Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
    [No Abstract]   [Full Text] [Related]  

  • 36. Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.
    Parsot C
    FEMS Microbiol Lett; 2005 Nov; 252(1):11-8. PubMed ID: 16182469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. O-specific side-chain toxin-protein conjugates as parenteral vaccines for the prevention of shigellosis and related diseases.
    Robbins JB; Chu C; Watson DC; Szu SC; Daniels EM; Lowe CU; Schneerson R
    Rev Infect Dis; 1991; 13 Suppl 4():S362-5. PubMed ID: 2047664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milk secretory IgA related to Shigella virulence antigens.
    Cleary TG; Hyani K; Winsor DK; Ruiz-Palacios G
    Adv Exp Med Biol; 1991; 310():369-73. PubMed ID: 1809012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Type three secretion system and pathogenesis of Shigella spp.--a review].
    Zhu L; Wang H
    Wei Sheng Wu Xue Bao; 2010 Nov; 50(11):1446-51. PubMed ID: 21268888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Penetration of Shigella into the epithelial cells as an important condition for the possible appearance of an infectious process].
    Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):24-8. PubMed ID: 4216216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.